ATPS-78PERSONALIZED CHEMOTHERAPY: TREATING BRAIN CANCERS WITH TARGETED NANOSYRINGES
نویسندگان
چکیده
منابع مشابه
Safe chemotherapy and targeted therapy for treating locally advanced NPC in a G6PD-deficient patient: case report and literature review
The article was first report a case of a 32-year-old female with NPC that is G6PD-deficient. The patient completed induction chemotherapy and concomitant chemoradiotherapy successfully. The patient experienced grade 1 neutropenia , grade 1 diarrhea, and grade 2 acne-like skin reactions during the three cycles of induction chemotherapy. Grade 1 neutropenia, grade 1 diarrhea, grade 2 oral mucosi...
متن کاملTargeted chemotherapy for triple-negative breast cancers via LHRH receptor.
Triple-negative breast cancer does not express estrogen and progesterone receptors and there is no overexpression/amplification of the HER2-neu gene. Therefore, this subtype of breast cancer lacks the benefits of specific therapies which target these receptors. About 60% of all human breast cancers express receptors for luteinizing hormone releasing hormone (LHRH, GnRH), which might be used as ...
متن کاملTargeted Chemotherapy with Metal Complexes.
Classical chemotherapeutics, such as cisplatin and its analogues, have been highly successful in the clinic, yet improvements can certainly be made, given the significant side effects associated with the killing of healthy cells. Recent advances in the field of chemotherapy include the development of targeted anticancer agents, compounds that are directed towards a specific biomarker of cancer,...
متن کامل5. Arbeitstagung Programmiersprachen (ATPS 2012)
Die Tagung dient dem Austausch zwischen Forschern, Entwicklern und Anwendern, die sich mit Themen aus dem Bereich der Programmiersprachen beschaeftigen. Alle Programmierparadigmen sind von Interesse: imperative, objektorientierte, funktionale, logische, parallele, graphische Programmiersprachen, auch verteilte und nebenlaeufige Programmierung in Intraund Internet-Anwendungen, sowie Konzepte zur...
متن کاملEffective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers.
Pancreatic cancer is the fourth commonest cause of cancer-related mortality across the world. Because of the poor response to conventional chemotherapy, small molecules, radiation therapy and surgery, development of new targeted therapies is necessary. In the present study, we have analyzed expression of the luteinizing hormone releasing hormone (LHRH) receptor in specimens of human pancreatic ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-Oncology
سال: 2015
ISSN: 1522-8517,1523-5866
DOI: 10.1093/neuonc/nov204.78